Back to search

Boston University

Direct-to-consumer marketing of psychological treatments: a randomized controlled trial

Abstract

dc:description.abstract

Progress in disseminating and implementing evidence-based psychological treatments (EBPTs) has been gradual. To date, the dominant target for promoting EBPTs in clinical settings has been the education and training of mental health providers, with many consumers remaining unaware of EBPTs' potential benefits. The present study empirically evaluated via a randomized controlled design the preliminary utility of direct-to-consumer (DTC) advertising of psychological treatments (PTs). American and Canadian undergraduate participants (N=344) were randomly assigned to view one of four commercial campaigns via the Internet on three occasions. Each campaign consisted of three different commercials embedded within unrelated content. Campaign content varied across participants, who were assigned to either the [1] Psychological Treatment (PT) campaign (n=98); [2] Psychological Treatment informing about Medication Side Effects (PT-MSE) campaign (n=80); [3] Medication (MED) campaign (n=82); or [4] the Neutral (NEU; i.e., control) campaign (n=84). The groups did not differ significantly on age or gender distribution. Data regarding attitudes about psychological treatment and treatment-seeking behaviors were collected prior to the intervention (T1), one week following the intervention (T2), and at a three-month follow-up evaluation (T3). It was hypothesized that those in the PT and PT-MSE conditions would have improved attitudes about psychological treatment and increased rates of seeking psychological treatment compared to those assigned to MED and NEU. The percentage of participants who newly intended psychological treatment at T2 or T3 differed by condition, with PT-MSE participants significantly more likely to have considered receiving psychological treatment than those in the other conditions. Those in PT were significantly more likely to have planned to receive psychological treatment at T2 or T3 than those in the other conditions. MED participants, as compared to participants in the other conditions, reported significantly increased levels of comfort about psychopharmacological treatment at T3. Baseline reports of DSM-IV symptomatology, stigma toward psychological treatments, media consumption, and nationality all significantly moderated various outcomes related to attitudes toward psychopharmacological and psychological treatment. The present study provides supporting evidence of the preliminary utility and efficacy of DTC marketing of PTs, suggesting that increasing consumer knowledge of PTs may be a worthwhile augmentation to EBPT dissemination and implementation efforts.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Psychological & Brain Sciences
Grantor
Boston University
Year dc:date.issued
2013

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gallo, Kaitlin P.

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/14131

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gallo, Kaitlin P.. Direct-to-consumer marketing of psychological treatments: a randomized controlled trial. doctoral thesis, Boston University, 2013. https://hdl.handle.net/2144/14131